Cargando…
NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
Background: Clear cell renal cell carcinoma (ccRCC) is the most frequent type of kidney cancer. Nck-associated protein 1 (NCKAP1) is associated with poor prognosis and tumor progression in several cancer types, but the function and prognostic value of NCKAP1 in ccRCC remain poorly understood. Method...
Autores principales: | Chen, Jiasheng, Ge, Jianzhang, Zhang, Wancong, Xie, Xuqi, Zhong, Xiaoping, Tang, Shijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360572/ https://www.ncbi.nlm.nih.gov/pubmed/35957696 http://dx.doi.org/10.3389/fgene.2022.764957 |
Ejemplares similares
-
The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM
por: Zhang, Wancong, et al.
Publicado: (2022) -
Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
por: Sun, Ming, et al.
Publicado: (2022) -
Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
por: Wei, Yuang, et al.
Publicado: (2021) -
Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Zhao, Guo-Jiang, et al.
Publicado: (2021) -
C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma
por: Yao, Wentao, et al.
Publicado: (2023)